Document is current
Any future updates will be listed below
-
Authors
Walker, Daisy
Moucheraud, Corrina
Butler, Derrick
Takayama, Christian
Shoptaw, Steven
Currier, Judith S.
Gladstein, Jay
Hoffman, Risa
-
Funding
Funding for this research was provided by:
California HIV/AIDS Research Program (H21IS3359)
- License Information
-
More Information
Article History
Received: 22 May 2024
Accepted: 13 December 2024
First Online: 31 December 2024
Declarations
:
: The study was approved by the Institutional Review Board at the University of California, Los Angeles (IRB #20-001508) and was conducted in accordance with the standards of the UCLA Human Research Protection Program (HRPP).
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Judith S. Currier served as a Scientific Advisor for Merck and Company in 2021. Jay Gladstein is on the Speaker Bureau for Gilead Sciences and ViiV Healthcare; he has also conducted clinical trials sponsored by both organizations. Risa Hoffman served on the Editorial Board of Elsevier’s Clinical Key during the time this project was completed. Corrina Moucheraud is an Associate Editor at Health Affairs Scholar. Daisy Walker, Derrick Butler, Christian Takayama, and Steven Shoptaw have no conflicts of interest to declare.
